-

Pearl’s Second Opinion® Introduces Groundbreaking AI-Assisted Radiology to Canadian Dentistry

Canada has joined a growing list of countries where Pearl’s flagship dental AI solution has been licensed for distribution.

LOS ANGELES--(BUSINESS WIRE)--Pearl, the leader in AI solutions for efficiency, accuracy, and consistency in dental care, today announced that it has received a Medical Device Establishment License (MDEL) for its Second Opinion® AI radiology solution from Canada Health. Second Opinion previously received CE-marking in Europe and TGA/MEDSAFE clearance in Australia and New Zealand for aiding dentists in their detection of a broad range of dental conditions via x-rays in accordance with patient and user safety standards.

The latest approval in Canada further indicates the integral role AI can play within the dental industry. Pearl was founded to bring transparency and objectivity to dentistry by applying computer vision to deliver solutions that improve consistency in radiologic interpretation, among other crucial tasks. Second Opinion® offers dentists an assistive tool to use when interpreting x-rays, helping build confidence in treatment recommendations for dentists and patients alike.

"Patients in Canada now have the opportunity to experience the benefits of AI-assisted dentistry first hand,” said Ophir Tanz, CEO and founder of Pearl. "Quality dental treatment starts with quality radiology and Second Opinion® allows dentists to optimize their works as radiologists, enabling them to consistently deliver need-based care of the highest standard.”

Second Opinion® applies computer vision technologies to detect a comprehensive array of pathologies, existing restorations and natural anatomy in dental radiographs. The system analyzes radiographs in real time, allowing dentists to display, review, add or reject the system’s detections while conducting exams in the operatory.

Dentists in Canada and other approved territories can begin using Pearl’s Second Opinion® today by visiting: www.hellopearl.com/products/second-opinion.

About Pearl

Pearl is shaping the future of dental care by delivering AI and computer vision solutions that advance efficiency, accuracy, transparency and patient care. Founded in 2019 by Ophir Tanz, Pearl is backed by Craft Ventures and other leading venture capital firms. For more information or to request a demonstration, please visit https://www.hellopearl.com.

Contacts

Alex Foley
Matter Health for Pearl
Pearl@matternow.com

Pearl


Release Summary
Pearl, the leader in AI solutions in dental care, received a Medical Device Establishment License (MDEL) for Second Opinion® AI radiology solution.
Release Versions

Contacts

Alex Foley
Matter Health for Pearl
Pearl@matternow.com

More News From Pearl

Pearl Names Eugene Katz Senior Vice President of Customer Success to Advance Provider-First Dental AI

LOS ANGELES--(BUSINESS WIRE)--Pearl, the global leader in dental AI solutions, today announced the appointment of Eugene Katz as Senior Vice President of Customer Success. In this newly created role, Katz will lead Pearl’s customer success organization, building on the company’s established provider-first approach to deepen adoption and ensure dental teams continue to realize meaningful value from Pearl’s AI in everyday practice. Katz brings more than a decade of experience leading customer suc...

Coast Dental Chooses Pearl to Power AI-Driven Care Across 88 Locations

LOS ANGELES--(BUSINESS WIRE)--Coast Dental, a patient-centric dental support organization serving nearly one million patients annually, has selected Pearl, the global leader in dental AI solutions, as its exclusive dental AI partner, deploying Pearl’s technology across its network of 88 practices. By choosing Pearl, Coast Dental is embedding AI as a foundational layer of intelligence across its clinical and operational environment. Rather than deploying AI as a standalone point solution limited...

Pearl Expands Dental AI Capabilities with FDA Clearance for Panoramic X-Rays

LOS ANGELES--(BUSINESS WIRE)--Pearl, the global leader in AI solutions for dentistry, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for AI-powered detection of dental pathologies on panoramic radiographs. This latest clearance expands Pearl’s clinically validated radiologic AI technology to the most widely captured extraoral imaging modality in dentistry, and is now available to Second Opinion® users in the U.S. and internationally. This clearance...
Back to Newsroom